FASN and pancreatic neoplasm: Previously, increased serum levels of fatty acid synthase, a metabolic enzyme that catalyses the synthesis of long-chain fatty acids, were observed in pancreatic cancer patients [48], and accumulation of long-chain fatty acids in the tumour microenvironment drove dysfunction in intra-pancreatic CD8+ T cells [49].